Beta-blockers and physical frailty in patients with end-stage liver disease

AIM: To investigate beta-blocker (BB) use in patients with cirrhosis and determine their effects on physical frailty and overall survival. METHODS: Adult outpatients with cirrhosis listed for liver transplantation underwent testing of physical frailty using the performance-based Liver Frailty Index,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Selena Z, Lizaola, Blanca, Hayssen, Hilary, Lai, Jennifer C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127661/
https://www.ncbi.nlm.nih.gov/pubmed/30197482
http://dx.doi.org/10.3748/wjg.v24.i33.3770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127661/
https://www.ncbi.nlm.nih.gov/pubmed/30197482
http://dx.doi.org/10.3748/wjg.v24.i33.3770

Ejemplares similares